CompletedNot Applicable

New Therapeutic Approach in Upper Limb Lymphedema Secondary to Breast Cancer: Activity-oriented Proprioceptive Antiedema Therapy (TAPA)

Spain51 participantsStarted 2019-03-01

Plain-language summary

This study evaluates the effectiveness of an experimental proposal therapy for upper limb lymphedema secondary to breast called Activity-oriented proprioceptive antiedema therapy (TAPA) facing the consensual gold standard treatment, the complete decongestive therapy. TAPA consists in: * Health education / patient empowerment. * Neurodynamic activities oriented to Activities of Daily Living (ADL). * Proprioceptive neuromuscular facilitation exercises oriented to ADL. * Self-adherent self-adhesive antiedema of low compression. Half of patients will receive TAPA treatment while the other half will receive CDT standard treatment.

Who can participate

Age range14 Years – 70 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Upper limb lymphedema secondary to breast cancer grade I and II, according to the Working Group of the XI International Lymphology Congress Exclusion Criteria: * Upper limb lymphedema secondary to breast cancer grade 0 and III, according to the Working Group of the XI International Lymphology Congress

What they're measuring

Volume

Timeframe: Baseline and 5 weeks

Circometry

Timeframe: Baseline and 5 weeks

Trial details

NCT IDNCT03762044

SponsorHospital Universitario Reina Sofia de Cordoba

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2021-09-01

View on ClinicalTrials.gov More Breast Cancer Lymphedema trials